AYTU (MC $16 M) (Cash $11.8 M) 4 Marketed Products +Big Drug

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical AYTU (MC $16 M) (Cash $11.8 M) 4 Marketed Products +Big Drug

Next 10

From: BioHero	10/12/2017 3:00:55 PM
	of 20

Don't you guys think that Aytu BioSciences Natesto, FDA approved, nasal TRT is far superior to Lipocines Tlando? gurufocus.com

Share	RecommendKeepReply Mark as Last Read

From: BioHero	10/13/2017 3:23:55 PM
	of 20

Lots of product launches expected in the coming weeks and months which means much much higher revenue .This lextreme low float stock is definitely terrible underpriced at this price and with Nasdaq listing in sight this stock will attract more institutional investors and with such low float this stock will explode to upside .GL ------ The 10 largest shareholders alone owned almost half of the outstanding shares of 4.2 million which is very strong . Armistice Capital LLC 405 641 Manchester Management Co. LLC 210 331 JEB Partners LP 200 000 Aigh Partners LP 181 500 Galileo Partners LLC 150 000 JMG Capital Management LLC 116 665 Joshua R. Disbrow, MBA 114 843 Jarrett T. Disbrow, PhD 113 384 Lincoln Park Capital Fund LLC 100 000 Triple Gate Capital GP LLC 100 000 Aytu BioScience Announces International Distribution Agreement for Fiera® in Japan fintel.io Aytu BioScience Expands MiOXSYS® Distribution Network with a Fertility-Focused Company in Over 20 Countries in Europe finance.yahoo.com

Share	RecommendKeepReply Mark as Last Read

From: BioHero	10/18/2017 9:50:30 AM
	of 20

Stock almost up 100% in last day and up today again AYTU will start trading on Nasdaq this week finance.yahoo.com

Share	RecommendKeepReply Mark as Last Read

From: Sultan	1/14/2018 3:08:02 PM
	of 20

Jan. 12 . Up 0.40 .. +17% closed at $2.80 .. vol. 252k stockcharts.com

Share	RecommendKeepReply Mark as Last Read

From: Sultan	3/8/2019 1:22:39 PM
	of 20

Aytu BioScience Reports 71% Revenue Growth in Q2 FY19 finance.yahoo.com

Share	RecommendKeepReply Mark as Last Read

From: Sultan	3/8/2019 1:23:40 PM
	of 20

Aytu BioScience Announces ZolpiMist (TM) Global Distribution Agreement with SUDA Pharmaceuticals finance.yahoo.com

Share	RecommendKeepReply Mark as Last Read

From: Sultan	3/19/2019 1:23:35 PM
	of 20

Aytu BioScience Announces Two Recent Publications Highlighting Improved Efficacy and Patient Preference of Natesto Nasal Testosterone over Topical Gels finance.yahoo.com

Share	RecommendKeepReply Mark as Last Read

From: Sultan	3/28/2019 4:07:53 PM
	of 20

Aytu BioScience Provides Study Update for Spermatogenesis Study of Natesto (R), the Only FDA-Approved, Nasally-Administered Testosterone Treatment finance.yahoo.com

Share	RecommendKeepReply Mark as Last Read

From: Sultan	9/13/2019 1:43:38 AM
	of 20

Aytu BioScience Announces Definitive Agreement to Acquire Innovus Pharmaceuticals finance.yahoo.com

Share	RecommendKeepReply Mark as Last Read

From: Sultan	2/14/2020 2:23:08 AM
	of 20

Aytu BioScience's (AYTU) CEO Josh Disbrow on Q2 2020 Results - Earnings Call Transcript seekingalpha.com

Share	RecommendKeepReply Mark as Last Read

Next 10